Sign inJoin waitlistJoin the waitlist

JR

Jonathan Rosenberg

Chief, Genitourinary Oncology Service, Division of Solid Tumor Oncology · New York Presbyterian Hospital

Credentials: · · · · · ·

History

Genitourinary Oncology Service Division · New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present

Research

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Nature · 2018 · 4,366 citations
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm,…
The Lancet · 2016 · First of 31 authors · Corresponding · 2,972 citations
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
The Lancet · 2017 · 1,812 citations

Joaquim Bellmunt
71 papers
DB
Dean Bajorin
67 papers
Matthew Galsky
54 papers
GI
Gopa Iyer
52 papers
BB
Bernard Bochner
49 papers
HA
Hikmat Al-Ahmadie
41 papers
Toni Choueiri
40 papers
David Solit
35 papers
GS
Guru Sonpavde
31 papers
Daniel Petrylak
28 papers
MT
Min Yuen Teo
27 papers
Evan Yu
25 papers

Clinical trials

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2003